ArticleOncotarget2016

Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism.

Lianne E Rotin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.